Expert evaluation of drugs as basic factor for development of recommended socioeconomic lists for the treatment of viral origin children enteritis

Authors

  • M. V. Balynska National University of Pharmacy, Ukraine

DOI:

https://doi.org/10.24959/nphj.16.2128

Keywords:

viral diarrhea, viral origin enteritis, expert evaluation, antidiarrheal drugs, socioeconomic lists of drugs, children

Abstract

In the article the results of a comprehensive expert evaluation of drugs for the treatment of viral diarrhea (VD) in children as an important stage in the development of regulatory socioeconomic lists (SEL) are presented. In particular the results of calculations of expert competency were given and was found that among the totality of respondents almost 15% of the experts have experience in the specialty for over 20 years, 50% - from 10 to 20 years of service, indicating the high experience of the physicians surveyed. In addition, 92% of experts have higher or the first qualification category, which confirms the high professional level of the respondents. It was established that 76% of the sample LP evaluated by competent experts were recommended for inclusion in recommended SEL for the treatment of VD in children. The calculations allowed to found the inclusion to recommended SEL of the last 19 drugs by trade names corresponding to the 5th pharmacological groups and an additional 3 drugs by INN. The results can be used in future to create the recommended insurance (primary and secondary) lists of drugs for pharmacotherapy VD in children if provided additional pharmacoeconomic studies that question remains relevant national health care system in the implementation of health insurance.

References

Наказ МОЗ України № 354 09.07.2004 «Про затвердження Протоколів діагностики та лікування інфекційних хвороб у дітей». Режим доступу: http://www.moz.gov.ua/ua/portal/dn_20040709_354.html

Наказ МОЗ України № 803 від 10.12.2007 «Про внесення змін до наказу МОЗ від 09.07.04 № 354». Режим доступу: http://www.moz.gov.ua/ua/portal/dn_20071210_803.html

Наказ МОЗ України від 31.03.2015 № 183 "Про затвердження сьомого випуску Державного формуляра лікарських засобів та забезпечення його доступності" Режим доступу: http://www.dec.gov.ua/index.php/ua/informatsijno-poshukova-sistema-elektronnij-formulyar

Немченко А.С. Оцінка стану фармакотерапії вірусних (секреторних) діарей у дітей (методичні рекомендації)/ А.С. Немченко, М.В. Балинська. – Харків. – 2016. – 19 с.

Немченко А.С. Oбгрунтування соціально-економічних переліків лікарських засобів для лікування ентеритів вірусного походження (вірусних діарей) у дітей (методичні рекомендації)/ А.С. Немченко, М.В. Балинська. – Харків. – 2016. – 22 с.

Diarrhoeal disease. Fact sheet N°330. Ресурс доступу: http://www.who.int/mediacentre/factsheets/fs330/en/

Nemchenko A.S. Intestinal infections in childhood: approaches to pharmacotherapy of viral diarrhea/ A.S. Nemchenko , M.V. Podgaina, D.V. Serdyuk, M.V. Balinska// Book of abstracts of XX international scientific and practical conference of young scientists and students “Actual questions of development of new drugs”, April 25-26, 2013. – Kh. – 2013. – P. 249.

Downloads

Published

2016-09-02

Issue

No. 3(87) (2016)

Section

Organization and Economy of Pharmacy

License

Copyright (c) 2016 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).